Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in AAPG held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | 16K | $383K | -4.0% | 0.005% | 0.00% |
| 2 | XY Capital Ltd | 13K | $311K | -4.5% | 0.004% | 0.33% |
| 3 | Tower Research Capital LLC (TRC) | 518 | $12K | +125.2% | 0.000% | 0.00% |
| 4 | MORGAN STANLEY | 498 | $12K | +225.5% | 0.000% | 0.00% |
| 5 | UBS Group AG | 124 | $3K | -97.1% | 0.000% | 0.00% |
| 6 | EverSource Wealth Advisors, LLC | 71 | $3K | +195.8% | 0.000% | 0.00% |
| 7 | ROYAL BANK OF CANADA | 6 | $0 | 0.0% | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in AAPG — a direct measure of their conviction.
Filings activity in AAPG during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new AAPG position in Q1 2026
No new institutional buyers this quarter.
Institutions that fully closed their AAPG position in Q1 2026
5 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 7 | 42% | 0.01% | 0.01 pp | $1M | 42% |
| Q4 2025 | 12 | 14% | 0.02% | 0.05 pp | $1M | 66% |
| Q3 2025 | 14 | +7.7% | 0.07% | +0.01 pp | $4M | +14% |
| Q2 2025 | 13 | +86% | 0.06% | 0.04 pp | $3M | 38% |
| Q1 2025 | 7 | — | 0.10% | — | $5M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying AAPG stock.
Based on Q1 2026 13F filings, institutional ownership of Ascentage Pharma Group International stands at 0.0%, held across 7 reporting institutions.
Point72 Asset Management, L.P. is the largest reported institutional holder of AAPG, with approximately 16,056 shares worth $0.00B as of Q1 2026.
Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of AAPG, including Point72 Asset Management, L.P..
Our composite Smart Money Score for AAPG is 30 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
0 institutions opened new positions in AAPG during Q1 2026, while 5 fully exited. 3 added to existing positions and 3 trimmed.
AAPG institutional ownership fell by 0.01 percentage points quarter-over-quarter, with a net change of -5 holders.
The top 10 institutions account for 100.0% of all reported 13F value in AAPG, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Ascentage Pharma Group International (AAPG) Institutional Ownership